← All companies
Celldex Therapeutics, Inc.
CLDX - CIK 0000744218
Market cap$2.35 B
Rank#1990
SEC filings1,268
The table below shows Celldex Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $35.73M | $36.04M | $23.04M | $17.14M | $36.40M | $42.74M |
| Short-term investments | $415.73M | $547.19M | $607.29M | $656.15M | $719.60M | $759.58M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.